This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
NEW YORK (Reuters Health) – In chronic obstructive pulmonary disease (COPD), vertebral deformities often contribute to excess height loss with aging – which in turn may lead to…
NEW YORK (Reuters Health) – The risk of hip fracture is significantly lower when organic nitrates are used as needed rather than continuously, according to a February 3rd…
NEW YORK (Reuters Health) – In patients with chest pain of uncertain origin, emergency department evaluation combining clinical history and N-terminal pro-B-type natriuretic peptide (NT-proBNP) level, without exercise…
NEW YORK (Reuters Health) – Three weeks of hypofractionated whole-breast radiotherapy is at least as good as 5 weeks of standard radiotherapy after breast-conserving surgery for invasive cancer,…
NEW YORK (Reuters Health) – In patients with psoriatic arthritis, once weekly etanercept (Enbrel) is suitable for joint symptoms but twice weekly dosing is needed to best address…
NEW YORK (Reuters Health) – Use of paroxetine during tamoxifen therapy reduces the breast cancer survival benefit by 25% or more depending on the amount of time the…
NEW YORK (Reuters Health) – With intensive medical therapy, fewer than 5% of patients with asymptomatic carotid stenosis will gain additional benefit from revascularization, according to a report…
NEW YORK (Reuters Health) – Type 2 diabetics treated with rosiglitazone are at increased risk of heart failure events, researchers report in the January 29th online issue of…
NEW YORK (Reuters Health) – Limiting thyroid tests to high-risk women will miss most cases of thyroid dysfunction during pregnancy, randomized trial results show. Furthermore, when low-risk women…
NEW YORK (Reuters Health) – Patients with Huntington’s disease treated with the investigational drug latrepirdine (dimebon) showed signs of improved cognitive function in a 3-month trial, investigators report.…
